| Name | Title | Contact Details |
|---|
Kerio Technologies is a San Jose, CA-based company in the Software and Internet sector.
Specialists in the provision of software licenses & support to cloud resellers globally. The original cloud marketplace, taking the strain so you dont have to.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Watermark Partners Real Estate: Managing for Investor Income and Community Growth
Replicus Software Corporation is a Palo Alto, CA-based company in the Software and Internet sector.